Anti-CD21 Anticorpo [LT21] (PE) (A85850)

Anticorpo monoclonale [LT21] di topo contro CD21 (PE) per Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Spese di spedizione
Tempi di consegna
4-6 Giorni lavorativi
Telefono
+1 (314) 370-6046
Lun - Ven, 8:00 - 16:00 AST
E-mail
orders@antibodies.com
Nome
Anti-CD21 Antibody [LT21] (PE)
Descrizione
Mouse monoclonal [LT21] antibody to CD21 (PE).
Specificità
This antibody reacts with an extracellular epitope of CD21, a 145 kDa transmembrane glycoprotein (complement C3d receptor - C3dR) expressed on B lymphocytes, follicular dendritic cells, some epithelial cells, and a subset of T lymphocytes. It is not expressed on immature B cells.
Applicazioni
Flow Cytometry
Diluizioni consigliate
Flow Cytometry: The reagent is designed for analysis of human blood cells using 20 µl reagent / 100 µl of whole blood or 106 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.
Reattività
Porcine, Human, Canine, Bovine
Immunogeno
IM9 human B-lymphoblastoid cell line.
Specie ospite
Mouse
Clonalità
Monoclonal
Clona ID
LT21
Isotipo
IgG1
Coniugare

PE

Excitation: 565nm, Emission: 578nm

Purificazione
This antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
MW previsto
145 kDa
Forma del prodotto
Liquid
Formulazione
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Conservazione
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Sinonimi
C3DR, CD 21, Complement C3d receptor, Complement C3d receptor 2, Complement component (3d/Epstein Barr virus) receptor 2, Complement receptor type 2, CR, Cr2, CR2_HUMAN, CVID7, EBV receptor, EBV-R, Epstein Barr virus receptor, Epstein-Barr virus receptor, EVBR, SLEB9
Dichiarazione di non responsabilità
Questo prodotto è solo per uso di ricerca. Non è inteso per uso diagnostico o terapeutico.

Prodotti alternativi a Anti-CD21 Anticorpo [LT21] (PE) (A85850)

Inizio pagina